Back to search

Article

Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease

2025-08-29

Abstract excerpt

<h4>ABSTRACT</h4> Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of kidney failure, marked by progressive cyst expansion, inflammation and fibrosis. Renal fibrosis, characterized by myofibroblast activation and excessive extracellular matrix (ECM) deposition is a central driver of disease progression in ADPKD, yet targeted anti-fibrotic therapies remain limited. Here, we evaluated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
53a0617b-ee98-584f-8c6f-4b571697bfcf
DOI
10.1101/2025.08.25.672225
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney diseaseDOI 10.1101/2025.08.25.672225
Select a neighboring publication to make it the new centre.